Funding to support Phase 1 clinical development of best-in-class PARG inhibitor candidate FORX-428 FORX-428 is potential new treatment option for patients whose cancers are resistant to, or have ...

FORX-428 is potential new treatment option for patients whose cancers are resistant to, or have become resistant to, PARP inhibitors Initial data expected in mid-2026 from open-label Phase 1 study in ...

Novel PARG inhibitor FORX-428 has shown best-in-class characteristics in preclinical studies Trial initially taking place in the U.S., following IND clearance Initial data expected in mid-2026 from ...

LEGO Mixels Series 6 - The Weldos Kramm, Forx, & Wuzzo Opening Build Review. Plus the Weldos Max. Found USA retail, Walmart Toys R Us, Target $4.99 each. Music: Dirt Road Traveler by Audionautix is ...

Opening, Building, and Looking at the Orange Packs Series 2 Lego Mixels Flexers Kraw, Tentro, and Balk. Found USA retail, Toys R Us $4.99 each. Trump reveals what he wants for the world 'Today' ...

Monica is a writer, artist, musician, and indie game developer, loving all things related to video games. She’s a woman with a bit of adoration for every game genre. From her first experience with ...

Industry veteran in clinical development of oncology therapeutics, Dr. Jens Wurthner, PhD, joins as Chief Medical Officer Lead development candidate, FORX-428, a PARG inhibitor for solid tumors, ...

BASEL, Switzerland--(BUSINESS WIRE)--FoRx Therapeutics AG, a Swiss-based company committed to discovering and developing innovative drugs targeting cancer-relevant DDR (DNA Damage Response) pathways, ...